Afucosylated anti-EBOV antibody MIL77-3 engages sGP to elicit NK cytotoxicity.
Yuting ZhangMin ZhangHaiyan WuXiaonan WuHang ZhengJunjuan FengMianjing WangJing WangLonglong LuoHe XiaoChunxia QiaoXinying LiYuanqiang ZhengWeijin HuangYouchun WangYi WangJiannan FengGuojiang ChenPublished in: Journal of virology (2024)
. Our work here uncovers the potential harmful influence of this modification on host immune responses, especially for mAbs with cross-reactivity to secreted glycoproptein (sGP) (e.g., MIL77-3), and highlights it is necessary to evaluate the NK-stimulating activity of a fucosylated mAb engaged with sGP when a new candidate is developed.